Skip Nav Destination
Issues
1 March 2011
-
Cover Image
Cover Image
The cover image shows a crown-like structure characterized by a necrotic adipocyte surrounded by macrophages in the mammary gland of an obese mouse. Macrophages were detected by immunohistochemical staining for F4/80. These inflammatory foci were previously described in visceral and subcutaneous fat of obese humans and mice but have not been reported for breast tissue. This image relates to a study (reported in this issue of the journal) of the obesity→inflammation→aromatase axis in the mammary gland and visceral fat that provides the first evidence suggesting a link between obesity, local inflammation in the mammary gland and risk of breast cancer. See articles by Subbaramaiah et al. (beginning on page 329) and Hursting (beginning on page 285) for more information. - PDF Icon PDF LinkTable of Contents
ISSN 1940-6207
EISSN 1940-6215
Issue Sections
Perspectives
Editorial
Commentary
Regulatory Approval of Cancer Risk-Reducing (Chemopreventive) Drugs: Moving What We Have Learned into the Clinic
Frank L. Meyskens, Jr.; Gregory A. Curt; Dean E. Brenner; Gary Gordon; Ronald B. Herberman; Olivera Finn; Gary J. Kelloff; Samir N. Khleif; Caroline C. Sigman; Eva Szabo; for the C-Change Chemoprevention Clinical Trials and Biomarkers Subcommittee
Insight
Research Articles
Obesity Is Associated with Inflammation and Elevated Aromatase Expression in the Mouse Mammary Gland
Kotha Subbaramaiah; Louise R. Howe; Priya Bhardwaj; Baoheng Du; Claudia Gravaghi; Rhonda K. Yantiss; Xi Kathy Zhou; Victoria A. Blaho; Timothy Hla; Peiying Yang; Levy Kopelovich; Clifford A. Hudis; Andrew J. Dannenberg
Phase 0 Clinical Chemoprevention Trial of the Akt Inhibitor SR13668
Joel M. Reid; Chad A. Walden; Rui Qin; Katie L. Allen Ziegler; John L. Haslam; Roger A. Rajewski; Roger Warndahl; Cindy L. Fitting; Daniel Boring; Eva Szabo; James Crowell; Marjorie Perloff; Ling Jong; Brent A. Bauer; Sumithra J. Mandrekar; Matthew M. Ames; Paul J. Limburg; for the Cancer Prevention Network
Ovarian Cancer Biomarker Performance in Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Specimens
Daniel W. Cramer; Robert C. Bast, Jr.; Christine D. Berg; Eleftherios P. Diamandis; Andrew K. Godwin; Patricia Hartge; Anna E. Lokshin; Karen H. Lu; Martin W. McIntosh; Gil Mor; Christos Patriotis; Paul F. Pinsky; Mark D. Thornquist; Nathalie Scholler; Steven J. Skates; Patrick M. Sluss; Sudhir Srivastava; David C. Ward; Zhen Zhang; Claire S. Zhu; Nicole Urban
A Framework for Evaluating Biomarkers for Early Detection: Validation of Biomarker Panels for Ovarian Cancer
Claire S. Zhu; Paul F. Pinsky; Daniel W. Cramer; David F. Ransohoff; Patricia Hartge; Ruth M. Pfeiffer; Nicole Urban; Gil Mor; Robert C. Bast, Jr.; Lee E. Moore; Anna E. Lokshin; Martin W. McIntosh; Steven J. Skates; Allison Vitonis; Zhen Zhang; David C. Ward; James T. Symanowski; Aleksey Lomakin; Eric T. Fung; Patrick M. Sluss; Nathalie Scholler; Karen H. Lu; Adele M. Marrangoni; Christos Patriotis; Sudhir Srivastava; Saundra S. Buys; Christine D. Berg; for the PLCO Project Team
Bioavailability of Sulforaphane from Two Broccoli Sprout Beverages: Results of a Short-term, Cross-over Clinical Trial in Qidong, China
Patricia A. Egner; Jian Guo Chen; Jin Bing Wang; Yan Wu; Yan Sun; Jian Hua Lu; Jian Zhu; Yong Hui Zhang; Yong Sheng Chen; Marlin D. Friesen; Lisa P. Jacobson; Alvaro Muñoz; Derek Ng; Geng Sun Qian; Yuan Rong Zhu; Tao Yang Chen; Nigel P. Botting; Qingzhi Zhang; Jed W. Fahey; Paul Talalay; John D Groopman; Thomas W. Kensler
Preventive Effects of (−)-Epigallocatechin Gallate on Diethylnitrosamine-Induced Liver Tumorigenesis in Obese and Diabetic C57BL/KsJ-db/db Mice
Masahito Shimizu; Hiroyasu Sakai; Yohei Shirakami; Yoichi Yasuda; Masaya Kubota; Daishi Terakura; Atsushi Baba; Tomohiko Ohno; Yukihiko Hara; Takuji Tanaka; Hisataka Moriwaki
Letters to the Editor
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.